SCHEMBL19081240

SCHEMBL19081240

CC1(C)c2c(ccc3ccccc23)-c2ccc3c(sc4ccc(-c5cccc(-c6c7ccccc7c(-c7ccc8ccccc8c7)c7ccccc67)c5)cc43)c21

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F9 P00740 4/20 0.32
CYP1A1 P04798 2/20 0.32
CYP1B1 Q16678 2/20 0.32
HSD17B1 P14061 1/20 0.32
HSD17B2 P37059 1/20 0.32
S1PR5 Q9H228 7/20 0.32
S1PR4 O95977 6/20 0.32
ALOX5 P09917 1/20 0.32
CHRNA1 P02708 1/20 0.31
CHRNG P07510 1/20 0.31
CHRNB1 P11230 1/20 0.31
CHRNB2 P17787 1/20 0.31
SLC6A2 P23975 1/20 0.31
CHRNB4 P30926 1/20 0.31
SLC6A4 P31645 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
SLC6A3 Q01959 1/20 0.31
CHRND Q07001 1/20 0.31
MAPK9 P45984 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081209 0.93 ALOX5 (0.33) F9CYP1A1CYP1B1ALOX5
SCHEMBL19081317 0.93 ALOX5 (0.33) S1PR5S1PR4ALOX5MAPK9MAPK14
SCHEMBL19081064 0.89 ALOX5 (0.35) F9CYP1A1CYP1B1ALOX5CYP1A2
SCHEMBL17944752 0.85 ALOX5 (0.35) HSD17B1HSD17B2S1PR5S1PR4ALOX5
SCHEMBL17247169 0.85 CYP1A1 (0.44) F9CYP1A1CYP1B1HSD17B1HSD17B2
SCHEMBL17247143 0.85 CYP1A1 (0.44) F9CYP1A1CYP1B1HSD17B1HSD17B2
SCHEMBL17247163 0.85 CYP1A1 (0.44) F9CYP1A1CYP1B1HSD17B1HSD17B2
SCHEMBL19081256 0.85 CHRNA1 (0.31) F9CYP1A1CYP1B1HSD17B1HSD17B2
SCHEMBL19081124 0.85 HSD17B1 (0.30) HSD17B1HSD17B2
SCHEMBL19081246 0.84 F9 (0.32) F9CYP1A1CYP1B1HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 F9 1203/4885CYP1A1 184/4885CYP1B1 260/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 F9 1203/4885CYP1A1 184/4885CYP1B1 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.